Location History:
- Dourban, FR (2014)
- Dourdan, FR (2002 - 2018)
Company Filing History:
11 out of 119 
4 out of 108 
Years Active: 2002-2018
Title: The Innovative Contributions of Christophe Lanco
Introduction
Christophe Lanco is a notable inventor based in Dourdan, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anti-proliferative activity. With a total of 15 patents to his name, Lanco's work is recognized for its potential impact on treating diseases linked to abnormal cell proliferation, such as cancer.
Latest Patents
Lanco's latest patents include Imidazolidine-2,4-dione derivatives, which are compounds that exhibit anti-proliferative activity. These derivatives are particularly useful for treating pathological states and diseases associated with abnormal cell proliferation, including cancer. His innovative approach in this area highlights the importance of research in developing effective treatments for serious health conditions.
Career Highlights
Throughout his career, Christophe Lanco has worked with prominent companies in the pharmaceutical industry. Notable among these are Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.) and Ipsen Pharma S.A.S. His experience in these organizations has contributed to his expertise and success as an inventor.
Collaborations
Lanco has collaborated with several professionals in his field, including Olivier Lavergne and Dennis Bigg. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions in the pharmaceutical sector.
Conclusion
Christophe Lanco's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his commitment to advancing medical science. His work in developing anti-proliferative compounds is a testament to the impact of innovation in addressing critical health challenges.